Biogen Switzerland AG
Biogen Switzerland AG is a Biotech company based in Baar (Zug) recorded by Swissmedic as the authorisation holder for 11 human medicines. That places it 134 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Biotechnologika.
Key facts
| Sector | Biotech |
|---|---|
| City | Baar |
| Canton | Zug |
| Authorisation holder | Yes |
| Medicines | 11 |
| Founded | 1996 |
| Employees | 201-1000 |
| Parent group | Biogen Inc. |
| Activity | Not available |
| Website | biogen.ch |
Medicines authorised in Switzerland
Biogen Switzerland AG is recorded by Swissmedic as the authorisation holder for 11 human medicines. The table shows 11 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
11 of 11 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Avonex | 56735 | B | L03AB07 | 2005-02-09 |
| Avonex Pen | 62178 | B | L03AB07 | 2011-11-09 |
| Plegridy 125 mcg/0.5 ml | 68280 | B | L03AB13 | 2022-03-01 |
| Plegridy Pen | 65242 | B | L03AB13 | 2015-07-08 |
| Qalsody | 68577 | A | N07XX22 | 2025-12-19 |
| Skyclarys 50 mg | 69610 | B | N07XX25 | 2024-09-24 |
| Spinraza 12mg/5ml | 66495 | A | M09AX | 2017-09-20 |
| Tecfidera 120 mg | 62831 | B | L04AX07 | 2014-08-07 |
| Tysabri 150 mg/ml | 68008 | B | L04AG03 | 2021-11-04 |
| Tysabri 300 mg | 57273 | B | L04AG03 | 2007-05-03 |
| Vumerity 231 mg | 68066 | B | L04AX09 | 2021-09-20 |
Frequently asked questions
How many medicines does Biogen Switzerland AG have authorised in Switzerland?
Biogen Switzerland AG is recorded by Swissmedic as the authorisation holder for 11 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Biogen Switzerland AG based?
The Swiss location recorded for Biogen Switzerland AG is Baar, Zug.
Is Biogen Switzerland AG a Swissmedic authorisation holder?
Yes. Biogen Switzerland AG appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.